SYNLAB UK & Ireland:

SYNLAB sets its Sights on Becoming the UK’s Leading Laboratory Diagnostics Organisation

Published: 23rd August 2023

Science for Life, Health and Wellbeing

SYNLAB, the medical diagnostics provider, has set out its ambition to become the UK’s leading  laboratory diagnostics organisation by 2027.

Across its three service areas of diagnostic and wellness testing, drug and alcohol testing, and NHS pathology partnerships, SYNLAB UK & Ireland currently delivers more than 63 million tests a year via its extensive laboratory network.

It has now unveiled a new vision, purpose and values which set a clear direction for the continued growth and success of each of its services in the UK – The Christie Pathology Partnership, Pathology First, Southwest Pathology Services, Synnovis, Lextox and SYNLAB Laboratory Services.

Man in white SYNLAB lab coat testing samples

There are two things that define our people. The first is a uniting passion for science and innovation, and the second is a true pride in our collective ability to make a real difference to people’s lives, health and wellbeing.

These themes came up time and again in conversations with colleagues across each of our service areas during the development of our vision and purpose, very clearly identifying who we are and our way forward.

As a result of these conversations, our core purpose was defined as making a positive difference to people’s lives, health and wellbeing through science, innovation and high-quality diagnostics.

Mark Dollar, Chief Executive Officer of SYNLAB UK & Ireland

In tandem with this core purpose, SYNLAB’s vision is that, by 2027, it will be recognised as the UK’s leading laboratory diagnostics organisation with people, quality and innovation consistently at its heart.

This vision and purpose underpin all that SYNLAB does – from the provision of pioneering pathology services to the acquisition and cultivation of the very best talent, from the delivery of outstanding quality standards that can be relied upon to make informed decisions to improving the environmental and social impact of the organisation as a whole.

I am very proud of what we have achieved together at SYNLAB to date. Aligning the focus and talent of more than 2,800 people behind a common purpose and vision for the UK marks a new chapter.

Success will be evident across our unique services offerings and the wider business by the sharing of learning and best practice; the co-development and delivery of innovative new services; recognised scientific excellence and advancement of clinical and operational practice; and access for all employees to great training, development and career opportunities, no matter where they are based.

I’m excited for the future and confident that, by working together, we can realise the potential of our ambitious organisation

Mark Dollar, Chief Executive Officer of SYNLAB UK & Ireland

More information about SYNLAB UK & Ireland’s new vision, core purpose, strategic priorities and values is available online at

Latest SYNLAB UK & Ireland News
Modern Slavery & Human Trafficking Statement 2023

Published: 11th July 2023 INTRODUCTION This is SYNLAB UK and Ireland’s (SYNLAB UK&I) Modern Slavery and Human Trafficking Statement under Section 54 of the UK…

Read More (about 'Modern Slavery & Human Trafficking Statement 2023')
Exceptional talent honoured during SYNLAB awards programme

Published: 8th December 2022 SYNLAB’s 2022 Excellence Awards recognised individuals and teams from across its UK & Ireland services, who display outstanding service in their…

Read More (about 'Exceptional talent honoured during SYNLAB awards programme')
SYNLAB Primed to Help Steer NHS’s COVID Bounce Back

Published: 13th October 2022 SYNLAB is ready to play a key role in assisting the UK’s ongoing COVID recovery after securing membership of NHS England’s…

Read More (about 'SYNLAB Primed to Help Steer NHS’s COVID Bounce Back')
Landmark Day for Pathology Partnership with Launch of Synnovis Brand

Published: 4th October 2022 A pathology partnership performing 32 million tests a year has been relaunched as ‘Synnovis’ – officially heralding the start of a…

Read More (about 'Landmark Day for Pathology Partnership with Launch of Synnovis Brand')
Pathology laboratory becomes the first in the UK to support remote plate reading  

Published: 15th June 2022 A pathology laboratory is leading the way in speeding up access to patient care and treatment after becoming the first in…

Read More (about 'Pathology laboratory becomes the first in the UK to support remote plate reading  ')
SYNLAB ESG Roadmap and Framework

Published: 17th May 2022 Introduction SYNLAB UK&I is thrilled to publish its UK&I ESG Framework and Roadmap, which outlines out how we will achieve our…

Read More (about 'SYNLAB ESG Roadmap and Framework')
GENDER Pay Gap Report 2020-21

Published: 21st September 2021 A Message From Our CEO Whilst we are pleased at the improvement in our gender pay gap over the past four…

Read More (about 'GENDER Pay Gap Report 2020-21')